MedEquities Realty Trust Inc (MRT) Director Sells $307,733.80 in Stock

MedEquities Realty Trust Inc (NYSE:MRT) Director Bluemountain Capital Managemen sold 35,783 shares of the company’s stock in a transaction that occurred on Thursday, November 8th. The shares were sold at an average price of $8.60, for a total value of $307,733.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Bluemountain Capital Managemen also recently made the following trade(s):

  • On Tuesday, November 6th, Bluemountain Capital Managemen sold 25,765 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.58, for a total value of $221,063.70.
  • On Friday, November 2nd, Bluemountain Capital Managemen sold 25,000 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.39, for a total value of $209,750.00.
  • On Wednesday, October 31st, Bluemountain Capital Managemen sold 10,000 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.45, for a total value of $84,500.00.
  • On Monday, October 29th, Bluemountain Capital Managemen sold 11,695 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.39, for a total value of $98,121.05.
  • On Thursday, October 25th, Bluemountain Capital Managemen sold 25,546 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.45, for a total value of $215,863.70.
  • On Monday, October 22nd, Bluemountain Capital Managemen sold 5,463 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.65, for a total value of $47,254.95.
  • On Friday, October 19th, Bluemountain Capital Managemen sold 5,000 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.54, for a total value of $42,700.00.
  • On Wednesday, October 17th, Bluemountain Capital Managemen sold 23,200 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.84, for a total value of $205,088.00.
  • On Friday, October 12th, Bluemountain Capital Managemen sold 10,000 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.74, for a total value of $87,400.00.
  • On Monday, October 15th, Bluemountain Capital Managemen sold 21,289 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.80, for a total value of $187,343.20.

Shares of MedEquities Realty Trust stock traded up $0.11 during trading hours on Friday, reaching $8.73. 170,034 shares of the company’s stock were exchanged, compared to its average volume of 126,070. MedEquities Realty Trust Inc has a 52-week low of $8.25 and a 52-week high of $12.00. The firm has a market cap of $271.79 million, a PE ratio of 7.66 and a beta of 0.65.

MedEquities Realty Trust (NYSE:MRT) last issued its quarterly earnings results on Friday, November 9th. The financial services provider reported ($0.07) earnings per share for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.35). The business had revenue of $9.68 million for the quarter, compared to analysts’ expectations of $17.72 million. MedEquities Realty Trust had a return on equity of 5.73% and a net margin of 30.84%. On average, analysts forecast that MedEquities Realty Trust Inc will post 1.08 EPS for the current fiscal year.

A number of research analysts have weighed in on MRT shares. Citigroup lowered MedEquities Realty Trust from a “neutral” rating to a “sell” rating and reduced their price target for the stock from $10.00 to $9.00 in a research note on Friday, September 14th. Canaccord Genuity reduced their price target on MedEquities Realty Trust from $13.00 to $12.00 and set an “overweight” rating on the stock in a research note on Thursday, August 9th. B. Riley set a $12.00 price target on MedEquities Realty Trust and gave the stock a “buy” rating in a research note on Thursday, August 9th. Zacks Investment Research raised MedEquities Realty Trust from a “strong sell” rating to a “hold” rating in a research note on Wednesday, October 10th. Finally, JMP Securities set a $12.00 price target on MedEquities Realty Trust and gave the stock a “buy” rating in a research note on Tuesday, October 23rd. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and three have given a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $11.25.

Several hedge funds have recently added to or reduced their stakes in the company. American Century Companies Inc. increased its holdings in shares of MedEquities Realty Trust by 7.1% during the 3rd quarter. American Century Companies Inc. now owns 2,325,880 shares of the financial services provider’s stock worth $22,608,000 after buying an additional 153,969 shares during the last quarter. BlackRock Inc. increased its holdings in shares of MedEquities Realty Trust by 14.8% during the 3rd quarter. BlackRock Inc. now owns 1,721,509 shares of the financial services provider’s stock worth $16,733,000 after buying an additional 222,015 shares during the last quarter. Renaissance Technologies LLC increased its holdings in shares of MedEquities Realty Trust by 36.0% during the 2nd quarter. Renaissance Technologies LLC now owns 839,800 shares of the financial services provider’s stock worth $9,255,000 after buying an additional 222,500 shares during the last quarter. Eagle Boston Investment Management Inc. increased its holdings in shares of MedEquities Realty Trust by 3.8% during the 3rd quarter. Eagle Boston Investment Management Inc. now owns 812,689 shares of the financial services provider’s stock worth $7,899,000 after buying an additional 29,828 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. increased its holdings in shares of MedEquities Realty Trust by 0.7% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 764,932 shares of the financial services provider’s stock worth $8,430,000 after buying an additional 5,106 shares during the last quarter. Institutional investors and hedge funds own 91.02% of the company’s stock.

TRADEMARK VIOLATION WARNING: “MedEquities Realty Trust Inc (MRT) Director Sells $307,733.80 in Stock” was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another domain, it was stolen and republished in violation of United States and international copyright laws. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/11/10/medequities-realty-trust-inc-mrt-director-sells-307733-80-in-stock.html.

About MedEquities Realty Trust

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Featured Article: How to invest in a bear market

Insider Buying and Selling by Quarter for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply